TY - JOUR
T1 - Healthcare-associated pneumonia
T2 - Approach to management
AU - Labelle, Andrew
AU - Kollef, Marin H.
PY - 2011/9/1
Y1 - 2011/9/1
N2 - Healthcare-associated pneumonia patients have worse outcomes and a different microbiologic profile than those with community-acquired pneumonia, including a greater risk for multidrug-resistant (MDR) organism infection. Risks include hospitalization for 2 or more days within 90 days, presentation from a nursing home or long-term care facility, attending a hospital or hemodialysis clinic, receiving intravenous therapy within 30 days, and immunosuppression. Ability to predict infection with MDR organisms varies, and the relative frequency of MDR organisms varies by geographic region. Initial treatment is broad-spectrum empiric antibiotics.
AB - Healthcare-associated pneumonia patients have worse outcomes and a different microbiologic profile than those with community-acquired pneumonia, including a greater risk for multidrug-resistant (MDR) organism infection. Risks include hospitalization for 2 or more days within 90 days, presentation from a nursing home or long-term care facility, attending a hospital or hemodialysis clinic, receiving intravenous therapy within 30 days, and immunosuppression. Ability to predict infection with MDR organisms varies, and the relative frequency of MDR organisms varies by geographic region. Initial treatment is broad-spectrum empiric antibiotics.
KW - Antibiotic therapy
KW - Community-acquired
KW - Healthcare-associated
KW - Pneumonia
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=80051868652&partnerID=8YFLogxK
U2 - 10.1016/j.ccm.2011.05.003
DO - 10.1016/j.ccm.2011.05.003
M3 - Review article
C2 - 21867819
AN - SCOPUS:80051868652
SN - 0272-5231
VL - 32
SP - 507
EP - 515
JO - Clinics in Chest Medicine
JF - Clinics in Chest Medicine
IS - 3
ER -